Need for high-quality studies in health technology assessments: The case of a systematic review of treatment for retinoblastoma

International Journal of Technology Assessment in Health Care

Volumn 22, Issue 4, 2006, Pages 408-418

  Mc Daid, Catriona M ^a,e   Hartley, Suzanne ^a,e   Bagnall, Anne Marie ^b   Ritchie, Gill ^c   Light, Kate ^a,e   Riemsma, Robert P ^d  

^a UNIVERSITY OF YORK   (United Kingdom)

^b LEEDS METROPOLITAN UNIVERSITY   (United Kingdom)

^c ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^d KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^e UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Brachytherapy; Chemotherapy; Enucleation; Radiotherapy; Retinoblastoma

Indexed keywords

CHEMOTHERAPY; DATABASE SYSTEMS; HEALTH CARE; HEALTH RISKS; MEDICAL PROBLEMS; PATIENT TREATMENT; RADIOTHERAPY;

BRACHYTHERAPY; CONTROLLED TRIALS; ENUCLEATION; RETINOBLASTOMA;

BIOMEDICAL ENGINEERING;

BIOMEDICAL TECHNOLOGY ASSESSMENT; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CHILDHOOD CANCER; CLINICAL OBSERVATION; CLINICAL TRIAL; ELECTRON THERAPY; ELECTRONIC MEDICAL RECORD; ENUCLEATION; HEALTH SERVICES RESEARCH; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; QUALITY CONTROL; RANDOMIZATION; RETINOBLASTOMA; REVIEW; SYSTEMATIC REVIEW;

CHILD; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME;

EID: 33750380810     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462306051324     Document Type: Review

References (52)

1. Abramson DH, Melson MR, Dunkel IJ, Frank CM. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology. 2001;108:1868-1876.
2. Akiyama K, Iwasaki M, Amemiya T, Yanai M. Chemotherapy for retinoblastoma. Ophthalmic Paediatr Genet. 1989;10:111-116.
3. Altman DG, Bland JM. Treatment allocation in controlled trials: Why randomise? BMJ. 1999;318:1209.
4. Amendola BE, Lamm FR, Markoe AM, et al. Radiotherapy of retinoblastoma. A review of 63 children treated with different irradiation techniques. Cancer. 1990;66:21-26.
5. Amendola BE, Markoe AM, Augsburger JJ, et al. Analysis of treatment results in 36 children with retinoblastoma treated by scleral plaque irradiation. Int J Radiat Oncol Biol Phys. 1989;17:63-70.
6. Antoneli CB, Steinhorst F, de Cassia Braga Ribeiro K, et al. Extraocular retinoblastoma: A 13-year experience. Cancer. 2003;98:1292-1298.
7. Blach LE, McCormick B, Abramson DH. External beam radiation therapy and retinoblastoma: Long-term results in the comparison of two techniques. Int J Radiat Oncol Biol Phys. 1996;35:45-51.
8. Cassady JR, Sagerman RH, Tretter P, Ellsworth RM. Radiation therapy in retinoblastoma. An analysis of 230 cases. Radiology. 1969;93:405-409.
9. Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. 2nd ed. York: Centre for Reviews and Dissemination; 2001.
10. de Sutter E, Havers W, Hopping W, Zeller G, Alberti W. The prognosis of retinoblastoma in terms of globe saving treatment. A computer assisted study part I. Ophthalmic Paediatr Genet. 1987;8:77-84.
11. de Sutter E, Havers W, Hopping W, Zeller G, Alberti W. The prognosis of retinoblastoma in terms of survival. A computer assisted study part II. Ophthalmic Paediatr Genet. 1987;8:85-88.
12. Deeks JJ, Dinnes J, D'Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:27.
13. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986;53:661-671.
14. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85:1121-1128.
15. Everitt BS. Cambridge dictionary of statistics in the medical sciences. Cambridge: Cambridge University Press; 1995.
16. Foote RL, Garretson BR, Schomberg PJ, et al. External beam irradiation for retinoblastoma: Patterns of failure and dose-response analysis. Int J Radiat Oncol Biol Phys. 1989;16:823-830.
17. Gallie BL, Erraguntla V, Heon E, Chan HSL. Retinoblastoma. In: Taylor D, Hoyt C, eds. Pediatric ophthalmology and strabismus. Philadelphia: WB Saunders; 2004:486-505.
18. Gunduz K, Shields CL, Shields JA, et al. The outcome of chemoreduction treatment in patients with Reese-Ellsworth Group V retinoblastoma. Arch Ophthalmol. 1998;116:1613-1617.
19. Hadjistilianou T, Greco G, Frezzotti R. Recurrent and new tumours during conservative treatment of bilateral retinoblastoma. Ophthalmic Paediatr Genet. 1991;12:79-84.
20. Hauffa BP, Liebers E, Bornfeld N, Sauerwein W, Havers W. Growth and development in children and adolescents after surgery, irradiation and chemotherapy for retinoblastoma. Monatsschr Kinderheilkd. 1995;143:1091-1098.
21. Haye C, Desjardins L, Elmaleh C, et al. Prognosis and treatment of retinoblastoma. 105 cases treated at the Curie Institute. Ophthalmic Paediatr Genet. 1989;10:151-155.
22. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120:923-931.
23. Hungerford J. Current status of retinoblastoma management [powerpoint presentation]. VIII Congreso de la Sociedad Española de Retina y Vítreo (Santiago de Compostela); 2004.
24. Hungerford JL, Toma NM, Plowman PN, Doughty D, Kingston JE. Whole-eye versus lens-sparing megavoltage therapy for retinoblastoma. Front Radiat Ther Oncol. 1997;30:81-87.
25. Kaste SC, Chen G, Fontanesi J, Crom DB, Pratt CB. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol. 1997;15:1183-1189.
26. Kim EW, Zakov ZN, Albert DM, Smith TR, Craft JL. Intraocular reticulum cell sarcoma: A case report and literature review. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979;209:167-178.
27. Lee TC, Hayashi NI, Dunkel IJ, et al. New retinoblastoma tumor formation in children initially treated with systemic carboplatin. Ophthalmology. 2003;110:1989-1994.
28. Lee V, Subak-Sharpe I, Hungerford JL, Davies NP, Logani S. Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology. 2000;107:940-945.
29. Mc Daid C, Hartley S, Bagnall A-M, et al. Systematic review of effectiveness of different treatments for childhood retinoblastoma. Health Technol Assess. 2005;9:48.
30. Meinert CL. Clinical trials dictionary: Terminology and usage recommendations. Baltimore: Johns Hopkins Center for Clinical Trials; 1996.
31. Merrill PT, Buckley EG, Halperin EC. New and recurrent tumors in germinal retinoblastoma: Is there a treatment effect? Ophthalmic Genet. 1996;17:115-118.
32. Messmer EP, Sauerwein W, Heinrich T, et al. New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol. 1990;228:426-431.
33. Mohr C, Fritze H, Messmer E, Heinrich T. The question of midface growth inhibition following retinoblastoma treatment in early childhood. Dtsch Z Mund Kiefer Gesichtschir. 1990;14:391-394.
34. Moll AC, Imhof SM, Schouten-Van Meeteren AY, et al. Second primary tumors in hereditary retinoblastoma: A register-based study, 1945-1997: Is there an age effect on radiation-related risk? Ophthalmology. 2001;108:1109-1114.
35. Murdoch IE, Morris SS, Cousens SN. People and eyes: Statistical approaches in opthalmology. Br J Ophthalmol. 1998;82:971-973.
36. Newcombe RG, Duff GR. Eyes or patients? Traps for the unwary in the statistical analysis of ophthalmological studies. Br J Ophthalmol. 1987;71:645-646.
37. Pasqualini T, Diez B, Gruneiro L, Domene H, Cassorla FG. Growth and endocrine function in children treated for retinoblastoma. J Pediatr Endocrinol. 1991;4:75-81.
38. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988;95:1583-1587.
39. Roth DB, Scott IU, Murray TG, et al. Echography of retinoblastoma: Histopathologic correlation and serial evaluation after globe-conserving radiotherapy or chemotherapy. J Pediatr Ophthalmol Strabismus. 2001;38:136-143.
40. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: How to practice and teach EBM. Edinburgh: Churchill Livingstone; 2000.
41. Sacks HS, Chalmers TC, Smith H. Randomized versus historical controls for clinical trials. Am J Med. 1982;72:233-240.
42. Scott IU, Murray TG, Feuer WJ, et al. External beam radiotherapy in retinoblastoma: Tumor control and comparison of 2 techniques. Arch Ophthalmol. 1999;117:766-770.
43. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol. 2001;119:1269-1272.
44. Shields CL, Shields JA, de Potter P. New treatment modalities for retinoblastoma. Curr Opin Ophthalmol. 1996;7:20-26.
45. Shields CL, Shields JA, Needle M, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1997;104:2101-2111.
46. Shields JA, Shields CL. Intraocular tumors: A text and atlas. Philadelphia: WB Saunders; 1992.
47. Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2000;37: 134-141.
48. Srivastava M, Vivekanand T, Malik GK, Bhadury S, Srivastava VK. Retinoblastoma. Indian Pediatr. 1984;21:875-879.
49. Sussman DA, Escalona-Benz E, Benz MS, et al. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol. 2003;121:979-984.
50. Wolff JA, Boesel CP, Dyment PG. Treatment of retinoblastoma: A preliminary report. In: Raybaud C, Clement R, Lebreuil G, eds. Pediatric oncology. Proceedings XIVth Meeting. International Society of Pediatric Oncology, 1981:364-368.
51. Wong FL, Boice JD, Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278:1262-1267.
52. Zucker JM, Desjardins L, Doz F. Retinoblastoma. Eur J Cancer. 1998;34:1045-1048.